XML 50 R40.htm IDEA: XBRL DOCUMENT v3.22.0.1
Other Investments (Tables)
12 Months Ended
Dec. 31, 2021
Investments, All Other Investments [Abstract]  
Schedule of other investments and proportionate share of earnings from equity method investments

The Company’s other investments and its proportionate share of earnings (losses) from equity method investments were as follows ($ in thousands):(1)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Carrying Value

​

Equity in Earnings (Losses)

​

​

As of December 31, 

    

For the Years Ended December 31, 

​

​

2021

    

2020

​

2021

    

2020

    

2019

Real estate equity investments

​

​

  

 

​

  

​

​

  

 

​

  

 

​

  

Safehold Inc. ("SAFE")(2)

​

$

1,168,532

​

$

937,712

​

$

108,393

​

$

53,476

​

$

29,764

Other real estate equity investments

​

 

61,979

​

 

89,939

​

 

36,606

​

 

(12,929)

​

 

12,620

Subtotal

​

 

1,230,511

​

 

1,027,651

​

 

144,999

​

 

40,547

​

 

42,384

Other strategic investments(3)

​

 

66,770

​

 

69,911

​

 

9,345

​

 

(1,075)

​

 

(6)

Total

​

$

1,297,281

​

$

1,097,562

​

$

154,344

​

$

39,472

​

$

42,378

(1)Refer to Note 3 - Net Lease Sale and Discontinued Operations.
(2)As of December 31, 2021, the Company owned 36.6 million shares of SAFE common stock which, based on the closing price of $79.85 on December 31, 2021, had a market value of $2.9 billion. Pursuant to ASC 323-10-40-1, an equity method investor shall account for a share issuance by an investee as if the investor had sold a proportionate share of its investment. Any gain or loss to the investor resulting from an investee’s share issuance shall be recognized in earnings. For the years ended December 31, 2021, 2020 and 2019, equity in earnings includes $60.7 million, $14.4 million and $7.6 million, respectively, of dilution gains resulting from SAFE equity offerings.
(3)During the years ended December 31, 2021 and 2020, the Company identified observable price changes in an equity security held by the Company as evidenced by orderly private issuances of similar securities by the same issuer. In accordance with ASC 321, the Company remeasured its equity investment at fair value and recognized aggregate mark-to-market gains during the years ended December 31, 2021 and 2020 of $18.9 million and $23.9 million, respectively, in “Other income” in the Company’s consolidated statements of operations. The Company’s equity security was redeemed at its carrying value in the fourth quarter of 2021.
Schedule of summarized financial information The following table presents the investee level summarized financial information of the Company’s equity method investments ($ in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

As of December 31, 

    

​

    

For the Years Ended December 31, 

​

    

2021

    

2020

    

​

    

2021

    

2020

    

2019

Balance Sheets

​

​

​

​

​

​

​

Income Statements

​

​

​

​

​

​

​

​

​

Total assets

​

$

6,107,890

​

$

4,184,503

​

Revenues

​

$

889,131

​

$

129,789

​

$

210,602

Total liabilities

​

 

3,019,208

​

 

2,250,720

​

Expenses

​

 

(254,001)

​

 

(188,605)

​

 

(176,887)

Noncontrolling interests

​

 

3,024

​

 

2,181

​

Net income (loss) attributable to parent entities

​

 

634,896

​

 

(59,010)

​

 

33,522

Total equity attributable to parent entities

​

 

3,085,657

​

 

1,931,602

​

  

​

 

  

​

 

  

​